Concise Review: Chemical Approaches for Modulating Lineage-Specific Stem Cells and Progenitors
Open Access
- 11 April 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 2 (5) , 355-361
Abstract
STEM CELLS Translational Medicine works to advance the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and helping speed translations of emerging lab discoveries into clinical trials, STEM CELLS Translational Medicine will help move applications of these critical investigations closer to accepted best practices and ultimately improve patient outcomes.Keywords
This publication has 53 references indexed in Scilit:
- Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signalingNature Biotechnology, 2009
- Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical InhibitorsCell Stem Cell, 2009
- NANOG Is a Direct Target of TGFβ/Activin-Mediated SMAD Signaling in Human ESCsCell Stem Cell, 2008
- A chemical approach to stem-cell biology and regenerative medicineNature, 2008
- Hematopoiesis: An Evolving Paradigm for Stem Cell BiologyCell, 2008
- Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectodermDevelopmental Biology, 2008
- A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damageNature Medicine, 2007
- Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic nicheBone Marrow Transplantation, 2006
- The ALK‐5 inhibitor A‐83‐01 inhibits Smad signaling and epithelial‐to‐mesenchymal transition by transforming growth factor‐βCancer Science, 2005
- Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac developmentBlood, 2005